Cargando…

Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy

The ability to cryopreserve natural killer (NK) cells has a significant potential in modern cancer immunotherapy. Current cryopreservation protocols cause deterioration in NK cell viability and functionality. This work reports the preservation of human cytokine‐activated NK cell viability and functi...

Descripción completa

Detalles Bibliográficos
Autores principales: El Assal, Rami, Abou‐Elkacem, Lotfi, Tocchio, Alessandro, Pasley, Shannon, Matosevic, Sandro, Kaplan, David L., Zylberberg, Claudia, Demirci, Utkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425501/
https://www.ncbi.nlm.nih.gov/pubmed/30937270
http://dx.doi.org/10.1002/advs.201802045
_version_ 1783404852248838144
author El Assal, Rami
Abou‐Elkacem, Lotfi
Tocchio, Alessandro
Pasley, Shannon
Matosevic, Sandro
Kaplan, David L.
Zylberberg, Claudia
Demirci, Utkan
author_facet El Assal, Rami
Abou‐Elkacem, Lotfi
Tocchio, Alessandro
Pasley, Shannon
Matosevic, Sandro
Kaplan, David L.
Zylberberg, Claudia
Demirci, Utkan
author_sort El Assal, Rami
collection PubMed
description The ability to cryopreserve natural killer (NK) cells has a significant potential in modern cancer immunotherapy. Current cryopreservation protocols cause deterioration in NK cell viability and functionality. This work reports the preservation of human cytokine‐activated NK cell viability and function following cryopreservation using a cocktail of biocompatible bioinspired cryoprotectants (i.e., dextran and carboxylated ε‐poly‐L‐lysine). Results demonstrate that the recovered NK cells after cryopreservation and rewarming maintain their viability immediately after thawing at a comparable level to control (dimethyl sulfoxide‐based cryopreservation). Although, their viability drops in the first day in culture compared to controls, the cells grow back to a comparable level to controls after 1 week in culture. In addition, the anti‐tumor functional activity of recovered NK cells demonstrates higher cytotoxic potency against leukemia cells compared to control. This approach presents a new direction for NK cell preservation, focusing on function and potentially enabling storage and distribution for cancer immunotherapy.
format Online
Article
Text
id pubmed-6425501
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64255012019-04-01 Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy El Assal, Rami Abou‐Elkacem, Lotfi Tocchio, Alessandro Pasley, Shannon Matosevic, Sandro Kaplan, David L. Zylberberg, Claudia Demirci, Utkan Adv Sci (Weinh) Communications The ability to cryopreserve natural killer (NK) cells has a significant potential in modern cancer immunotherapy. Current cryopreservation protocols cause deterioration in NK cell viability and functionality. This work reports the preservation of human cytokine‐activated NK cell viability and function following cryopreservation using a cocktail of biocompatible bioinspired cryoprotectants (i.e., dextran and carboxylated ε‐poly‐L‐lysine). Results demonstrate that the recovered NK cells after cryopreservation and rewarming maintain their viability immediately after thawing at a comparable level to control (dimethyl sulfoxide‐based cryopreservation). Although, their viability drops in the first day in culture compared to controls, the cells grow back to a comparable level to controls after 1 week in culture. In addition, the anti‐tumor functional activity of recovered NK cells demonstrates higher cytotoxic potency against leukemia cells compared to control. This approach presents a new direction for NK cell preservation, focusing on function and potentially enabling storage and distribution for cancer immunotherapy. John Wiley and Sons Inc. 2019-01-27 /pmc/articles/PMC6425501/ /pubmed/30937270 http://dx.doi.org/10.1002/advs.201802045 Text en © 2019 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Communications
El Assal, Rami
Abou‐Elkacem, Lotfi
Tocchio, Alessandro
Pasley, Shannon
Matosevic, Sandro
Kaplan, David L.
Zylberberg, Claudia
Demirci, Utkan
Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
title Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
title_full Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
title_fullStr Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
title_full_unstemmed Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
title_short Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
title_sort bioinspired preservation of natural killer cells for cancer immunotherapy
topic Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425501/
https://www.ncbi.nlm.nih.gov/pubmed/30937270
http://dx.doi.org/10.1002/advs.201802045
work_keys_str_mv AT elassalrami bioinspiredpreservationofnaturalkillercellsforcancerimmunotherapy
AT abouelkacemlotfi bioinspiredpreservationofnaturalkillercellsforcancerimmunotherapy
AT tocchioalessandro bioinspiredpreservationofnaturalkillercellsforcancerimmunotherapy
AT pasleyshannon bioinspiredpreservationofnaturalkillercellsforcancerimmunotherapy
AT matosevicsandro bioinspiredpreservationofnaturalkillercellsforcancerimmunotherapy
AT kaplandavidl bioinspiredpreservationofnaturalkillercellsforcancerimmunotherapy
AT zylberbergclaudia bioinspiredpreservationofnaturalkillercellsforcancerimmunotherapy
AT demirciutkan bioinspiredpreservationofnaturalkillercellsforcancerimmunotherapy